Repeat Administration of Triamcinolone Acetonide Extended-Release Affords Consistent, Clinically Relevant Improvements in Pain: Results From a Phase 3B, Single-Arm, Open-Label Study

Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2019.02.570
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Local Effects Following Single and Repeat Intra-Articular Injections of Triamcinolone Acetonide Extended-Release: Results From Three Nonclinical Toxicity Studies in Dogs

Rheumatology and Therapy
2018English

Safety and Systemic Exposure of Triamcinolone Acetonide Following Intra-Articular Injection of Triamcinolone Acetonide Extended-Release or Standard Triamcinolone in Patients With Hip Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Expanding the Potential of Nonoperative Therapies in Advanced Knee Osteoarthritis: Treatment Response to Repeat Administration Triamcinolone Acetonide Extended-Release Is Similar Across Kellgren-Lawrence Grades 2-4

Orthopaedic Journal of Sports Medicine
OrthopedicsSports Medicine
2019English

Improvement in Social and Cognitive Functioning Associated With Paliperidone Extended-Release Treatment in Patients With Schizophrenia: A 24-Week, Single Arm, Open-Label Study

Neuropsychiatric Disease and Treatment
2016English

Efficacy, Safety and Pharmacokinetics of Subcutaneous Azacitidine in Chinese Patients With Higher Risk Myelodysplastic Syndromes: Results From a Multicenter, Single-Arm, Open-Label Phase 2 Study

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

Triamcinolone Acetonide

Reactions
1980English

Once-Weekly Ofatumumab in Untreated or Relapsed Waldenström's Macroglobulinaemia: An Open-Label, Single-Arm, Phase 2 Study

The Lancet Haematology
Hematology
2017English

Rescue Analgesic Medication Use by Patients Treated With Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical Trials

Pain and Therapy
NeurologyAnesthesiologyPain Medicine
2019English

Efficacy and Safety of Privigen®in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: Results of a Prospective, Single-Arm, Open-Label Phase III Study (The PRIMA Study)

Journal of the Peripheral Nervous System
MedicineNeuroscienceNeurology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy